An overview of the immunopathology of human paracoccidioidomycosis.
We review here the advances in the understanding of the immunopathology of human paracoccidioidomycosis (PCM). Its investigation must take in account the intriguing natural history of the mycosis and its agent, providing clues to the mechanisms that lead to development of disease (unbalanced host-parasite relationship?) or to the clinically silent, chronic carrier state (balanced host-parasite relationship?), in exposed people living in endemic areas. Although the literature on this subject has progressed notably, the overall picture of what are the mechanisms of susceptibility or resistance continues to be fragmentary. Major advances were seen in the description of both the cytokines/chemokines associated to the different outcomes of the host-parasite interaction, and the fungus-monocyte/macrophage interaction, and cytokines released thereof by these cells. However, relatively few studies have attempted to modify, even in vitro, the patients' unbalanced immune reactivity. Consequently, the benefits of this improved knowledge did not yet reach clinical practice. Fortunately, the previous notion of the immune system as having two nearly independent arms, the innate and adaptive immunities, leaving a large gap between them, is now being overcome. Immunologists are now trying to dissect the connections between these two arms. This will certainly lead to more productive results. Current investigations should address the innate immunity events that trigger the IL-12/IFN-gamma axis and confer protection against PCM in those individuals living in endemic areas, who have been infected, but did not develop the mycosis.
Benard
Gil
G
Laboratory of Dermatology and Immunodeficiencies (LIM-56), Medical School of the University of São Paulo, Av. Dr. Enéas de Carvalho Aguiar 500 3 floor, Sao Paulo, Brazil. mahong@usp.br
D016207:Cytokines / Q000096:biosynthesis / Q000276:immunology; D054884:Host-Pathogen Interactions; D006801:Humans; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D010228:Paracoccidioides / Q000276:immunology / Q000502:physiology*; D010229:Paracoccidioidomycosis / Q000276:immunology* / Q000382:microbiology / Q000503:physiopathology*; D013601:T-Lymphocytes / Q000276:immunology
D016207:Cytokines
J Med Vet Mycol. 1988 Apr;26(2):105-11
2971102
Mycopathologia. 1982 Aug 20;79(2):115-23
6982417
Med Mycol. 2000 Jun;38(3):225-9
10892991
Sabouraudia. 1978 Jun;16(2):151-63
694716
J Immunol. 1996 Sep 15;157(6):2348-57
8805632
Microbes Infect. 2002 Feb;4(2):139-44
11880044
J Clin Invest. 1997 Dec 1;100(11):2658-64
9389728
Clin Immunol. 2002 Nov;105(2):215-22
12482396
J Allergy Clin Immunol. 2007 Mar;119(3):529-41; quiz 542-3
17336608
Clin Exp Immunol. 2007 Mar;147(3):483-90
17302897
Microbes Infect. 1999 Apr;1(5):353-60
10602668
J Med Vet Mycol. 1987 Feb;25(1):5-18
3553526
Mol Med. 2003 Sep-Dec;9(9-12):209-19
15208742
Med Mycol. 2003 Apr;41(2):89-96
12964840
Rev Soc Bras Med Trop. 1987 Apr-Jun;20(2):129-32
3507739
Cell Immunol. 1976 Jun 15;24(2):365-78
779977
J Immunol. 2006 Nov 1;177(9):5811-8
17056505
Clin Infect Dis. 2005 Aug 15;41(4):e31-7
16028144
Cytokine. 2003 Mar 7;21(5):234-41
12824008
J Med Vet Mycol. 1986 Dec;24(6):445-54
3572679
Microbes Infect. 2005 Jan;7(1):55-65
15716071
Rev Inst Med Trop Sao Paulo. 1984 Sep-Oct;26(5):267-71
6099907
Am J Pathol. 2000 May;156(5):1811-20
10793093
Rev Inst Med Trop Sao Paulo. 2005 Sep-Oct;47(5):257-62
16302108
Clin Exp Immunol. 1977 Apr;28(1):89-98
862251
Clin Diagn Lab Immunol. 2001 Sep;8(5):1036-8
11527826
J Eur Acad Dermatol Venereol. 2000 May;14(3):166-71
11032058
J Exp Med. 2000 Oct 2;192(7):1027-34
11015443
Am J Trop Med Hyg. 1996 Jan;54(1):7-12
8651374
Microbes Infect. 2004 Jul;6(8):759-66
15207823
Immunology. 2001 Apr;102(4):480-5
11328382
Sabouraudia. 1983 Mar;21(1):35-9
6405491
Br J Dermatol. 2006 Apr;154(4):643-50
16536806
Cytokine. 2002 May 7;18(3):149-57
12126651
Microbes Infect. 2003 Feb;5(2):107-13
12650768
J Med Vet Mycol. 1995 Jan-Feb;33(1):67-71
7650582
J Infect Dis. 1997 May;175(5):1263-7
9129101
Med Mycol. 1999 Aug;37(4):277-84
10421863
Nat Rev Mol Cell Biol. 2002 Sep;3(9):651-62
12209125
Rev Soc Bras Med Trop. 2007 Mar-Apr;40(2):156-62
17568881
Infect Immun. 1980 May;28(2):557-66
6995312
Cytokine. 2001 Feb 21;13(4):248-52
11237434
Am J Trop Med Hyg. 1996 Oct;55(4):391-8
8916794
Med Mycol. 2005 Aug;43(5):417-22
16178370
Clin Immunol. 2005 Jan;114(1):86-94
15596413
J Allergy Clin Immunol. 1971 Jul;48(1):40-5
4932975
Rev Inst Med Trop Sao Paulo. 2005 Sep-Oct;47(5):263-6
16302109
Eur Respir J. 2003 Dec;22(6):895-9
14680075
J Infect Dis. 2003 May 1;187(9):1496-505
12717632
Immunobiology. 2005;210(2-4):63-76
16164013
J Med Microbiol. 1994 Mar;40(3):159-64
8114064
J Cell Mol Med. 2003 Oct-Dec;7(4):475-86
14754517
Clin Infect Dis. 2000 Oct;31(4):1032-9
11049788
J Med Vet Mycol. 1988;26(4):253-6
3216280
Clin Vaccine Immunol. 2007 Apr;14(4):474-6
17329443
Curr Opin Rheumatol. 2005 May;17(3):305-11
15838241
Microbes Infect. 2003 Apr;5(5):413-8
12737997
Med Mycol. 2007 Feb;45(1):35-40
17325942
Clin Infect Dis. 2003 Oct 1;37(7):898-904
13130400
Med Mycol. 2000 Apr;38(2):177-82
10817235
Hospital (Rio J). 1948 Sep;34(3):313-26
18886753
Med Mycol. 2007 Feb;45(1):27-33
17325941
J Immunol. 2002 May 1;168(9):4593-600
11971007
Mycopathologia. 1983 Dec 1;84(1):55-63
6672635
Infect Immun. 1998 Feb;66(2):786-93
9453642
Nat Immunol. 2005 Apr;6(4):338-44
15785759
Cytokine. 2006 Aug;35(3-4):207-16
17045486
Med Mycol. 2006 Jun;44(4):363-8
16772231
Hum Immunol. 2002 Feb;63(2):149-54
11821163
Mycopathologia. 1991 May;114(2):89-91
1875988
Cytokine. 2005 Oct 7;32(1):20-9
16174562
Braz J Med Biol Res. 1989;22(2):205-12
2790289
Hum Genet. 2003 Mar;112(3):237-43
12596048
J Med Vet Mycol. 1995 Jul-Aug;33(4):223-7
8531019
J Med Vet Mycol. 1989;27(3):149-58
2528613
Trans R Soc Trop Med Hyg. 1985;79(6):765-72
3832489
Am J Dermatopathol. 2003 Apr;25(2):107-12
12652191
Immunol Lett. 2006 Mar 15;103(2):121-6
16298431
Hum Immunol. 2006 Nov;67(11):931-9
17145373